Dolutegravir intermediate-1
CAS No. 1335210-23-5
Dolutegravir intermediate-1 ( 1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid; 1-(2,2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid )
Catalog No. M23489 CAS No. 1335210-23-5
Dolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
100MG | 38 | In Stock |
|
500MG | 52 | In Stock |
|
1G | 67 | In Stock |
|
Biological Information
-
Product NameDolutegravir intermediate-1
-
NoteResearch use only, not for human use.
-
Brief DescriptionDolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2.
-
DescriptionDolutegravir intermediate-1 is a new synthetic Dolutegravir intermediate extracted from patent WO 2016125192 A2. Dolutegravir is an integrase inhibitor developed for the treatment of human immunodeficiency virus (HIV)-1 infection.
-
Synonyms1-(2,2-dimethoxyethyl)-5-methoxy-6-(methoxycarbonyl)-4-oxo-1,4-dihydropyridine-3-carboxylic acid; 1-(2,2-dimethoxyethyl)-5-methoxy-6-methoxycarbonyl-4-oxopyridine-3-carboxylic acid
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV-1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1335210-23-5
-
Formula Weight314.3
-
Molecular FormulaC13H16NO8
-
Purity>98% (HPLC)
-
SolubilityDMSO: 100 mg/mL (285.46 mM; Need ultrasonic)
-
SMILESCOC(CN(C=C(C([O-])=O)C1=O)C(C(OC)=O)=C1OC)OC
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Sivaram Prasad, et al. Process for the preparation of dolutegravir . WO 2016125192 A2.
molnova catalog
related products
-
Zidovudine
A nucleoside reverse transcriptase inhibitor (NRTI) that used to prevent and treat HIV/AIDS.
-
Enfuvirtide
Enfuvirtide (INN) is an HIV fusion inhibitor, the first of a class of antiretroviral drugs used in combination therapy for the treatment of HIV-1 infection.
-
GS-6207
GS-6207 (GS6207, GS-CA1) is a potent, selective inhibitor of HIV-1 capsid function with potency and potential to be clinically effective against a broad range of HIV-1 strains.